Laurion Capital Management LP Akebia Therapeutics, Inc. Transaction History

Laurion Capital Management LP

  • $7.27 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$5.39 - $9.15 $535,340 - $908,787
-99,321 Closed
0 $0
Q3 2018

Nov 13, 2018
SELL
$7.44 - $10.65 $3.1 Million - $4.43 Million
-416,186 Reduced 80.73%
99,321 $877,000
Q2 2018

Aug 13, 2018
SELL
$9.15 - $11.34 $4.09 Million - $5.07 Million
-446,791 Reduced 46.43%
515,507 $5.15 Million
Q1 2018

May 14, 2018
BUY
$9.53 - $15.68 $9.17 Million - $15.1 Million
962,298 New
962,298 $9.17 Million

Others Institutions Holding AKBA

# of Institutions
120
Shares Held
54.8M
Call Options Held
291K
Put Options Held
179K
View Full List

About Akebia Therapeutics, Inc.

AKBA Quotes by TradingView
  • Ticker AKBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 183,848,992
  • Market Cap $329M
  • Description
  • Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...
More about AKBA
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email